Point mutations and genomic deletions of the NF1 gene were found in 10.5% of the myxofibrosarcomas and 8% of the pleomorphic liposarcomas in 207 samples of STSs (Barretina et al., 2010). The gene discussed is NF1; the disease is myxofibrosarcoma.